You just read:

Daiichi Sankyo Presents Preliminary Phase 1 Data for Antibody Drug Conjugate U3-1402 in Patients with HER3-Expressing Breast Cancer at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

News provided by

Daiichi Sankyo Company, Limited

01 Jun, 2018, 13:00 BST